» Articles » PMID: 3399891

Molecular Characterization of a Functional CDNA Encoding the Serotonin 1c Receptor

Overview
Journal Science
Specialty Science
Date 1988 Jul 29
PMID 3399891
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

Neurons that release serotonin as a neurotransmitter project to most regions of the central and peripheral nervous system and mediate diverse neural functions. The physiological effects of serotonin are initiated by the activation of multiple, distinct receptor subtypes. Cloning in RNA expression vectors was combined with a sensitive electrophysiological assay in Xenopus oocytes in order to isolate a functional cDNA clone encoding the 5HTlc serotonin receptor. Injection of RNA transcribed in vitro from this clone into Xenopus oocytes elicits serotonin sensitivity. Mouse fibroblasts transformed with this clone bind serotonin agonists and antagonists and exhibit an increase in intracellular Ca2+ concentrations in response to serotonin. The sequence of the 5HTlc receptor reveals that it belongs to the family of G protein-coupled receptors, which are thought to traverse the cytoplasmic membrane seven times. Moreover, in situ hybridization and RNA blot analysis indicate that the 5HTlc receptor is expressed in neurons in many regions of the central nervous system and suggest that this subclass of receptor may mediate many of the central actions of serotonin.

Citing Articles

Identification of Spiro[chromene-2,4'-piperidine]s as Potent, Selective, and G-Biased 5-HT Receptor Partial Agonists.

Jiang G, Zhang B, Zhang X, Chen F, Qin W, Chen J ACS Med Chem Lett. 2024; 15(1):99-106.

PMID: 38229745 PMC: 10788947. DOI: 10.1021/acsmedchemlett.3c00454.


Nobel somatosensations and pain.

Reeh P, Fischer M Pflugers Arch. 2022; 474(4):405-420.

PMID: 35157132 PMC: 8924131. DOI: 10.1007/s00424-022-02667-x.


International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.

Barnes N, Ahern G, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S Pharmacol Rev. 2020; 73(1):310-520.

PMID: 33370241 PMC: 7770494. DOI: 10.1124/pr.118.015552.


Cardiovascular effects of antiobesity drugs: are the new medicines all the same?.

Cataldi M, Cignarelli A, Giallauria F, Muscogiuri G, Barrea L, Savastano S Int J Obes Suppl. 2020; 10(1):14-26.

PMID: 32714509 PMC: 7371629. DOI: 10.1038/s41367-020-0015-3.


A Novel Synthetic Interfering Peptide Tat-3L4F Attenuates Olanzapine-Induced Weight Gain Through Disrupting Crosstalk Between Serotonin Receptor 2C and Protein Phosphatase and Tensin Homolog in Rats.

Wang Y, Wang D, Chen Y, Fang X, Yu L, Zhang C Int J Neuropsychopharmacol. 2020; 23(8):481-490.

PMID: 32710540 PMC: 7689208. DOI: 10.1093/ijnp/pyaa001.